Jeffrey Su

Jeffrey Su

Presidente en Bioserv Corp. .

Health Technology
Commercial Services
Consumer Services

Perfil

Jeffrey Su is currently the President at Bioserv Corp.
and Partner & CSO at CLI Ventures.
Previously, he worked as the Director-Process & Analytical Development at The Dow Chemical Co., Associate Director at Tanox, Inc., Senior Director at CancerVax Corp., Deputy Director at Sanofi Pasteur, Inc., Principal at Medarex, Inc. and Human Genome Sciences, Inc., Chief Scientific & Development Officer at Cytovance Biologics, Inc., Vice President at Femta Pharmaceuticals, Inc., and Chief Operating Officer & Executive Vice President at Sorrento Therapeutics, Inc. He also worked as a Principal at Pharming Healthcare, Inc. and Roche (Brussels).
Dr. Su holds a doctorate degree from Carleton University and a graduate degree from Nankai University.

Cargos activos de Jeffrey Su

EmpresasCargoInicio
Inversor de Capital Privado -
Presidente -
Todos los cargos activos de Jeffrey Su

Antiguos cargos conocidos de Jeffrey Su.

EmpresasCargoFin
SORRENTO THERAPEUTICS, INC. Director de Operaciones 30/06/2017
Corporate Officer/Principal -
CancerVax Corp. Corporate Officer/Principal 01/11/2006
DOW CHEMICAL COMPANY (THE) Corporate Officer/Principal 01/07/2004
Corporate Officer/Principal 01/02/2003
Ver el detalle de la experiencia de Jeffrey Su.

Formación de Jeffrey Su.

Carleton University Doctorate Degree
Nankai University Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jeffrey Su.

Relaciones

100 +

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
SORRENTO THERAPEUTICS, INC.

Health Technology

Empresas privadas12

Process Industries

Commercial Services

Health Technology

Health Technology

CancerVax Corp.

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Roche (Brussels)

Finance

Ver las conexiones de la empresa